Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

陶氏病 疾病 医学 生物标志物 痴呆 工作组 无症状的 心理学 病理 神经退行性变 计算机科学 生物 计算机网络 生物化学
作者
Clifford R. Jack,Jeffrey Scott Andrews,Thomas G. Beach,Teresa Buracchio,Billy Dunn,Ana Graf,Oskar Hansson,Carole Ho,William J. Jagust,Eric McDade,José Luís Molinuevo,Ozioma C. Okonkwo,Luca Pani,Michael S. Rafii,Philip Scheltens,Eric Siemers,Heather M. Snyder,Reisa Anne Sperling,Charlotte Elisabeth Teunissen,María C. Carrillo
出处
期刊:Alzheimers & Dementia [Wiley]
卷期号:20 (8): 5143-5169 被引量:3139
标识
DOI:10.1002/alz.13859
摘要

The National Institute on Aging and the Alzheimer's Association convened three separate work groups in 2011 and single work groups in 2012 and 2018 to create recommendations for the diagnosis and characterization of Alzheimer's disease (AD). The present document updates the 2018 research framework in response to several recent developments. Defining diseases biologically, rather than based on syndromic presentation, has long been standard in many areas of medicine (e.g., oncology), and is becoming a unifying concept common to all neurodegenerative diseases, not just AD. The present document is consistent with this principle. Our intent is to present objective criteria for diagnosis and staging AD, incorporating recent advances in biomarkers, to serve as a bridge between research and clinical care. These criteria are not intended to provide step-by-step clinical practice guidelines for clinical workflow or specific treatment protocols, but rather serve as general principles to inform diagnosis and staging of AD that reflect current science. HIGHLIGHTS: We define Alzheimer's disease (AD) to be a biological process that begins with the appearance of AD neuropathologic change (ADNPC) while people are asymptomatic. Progression of the neuropathologic burden leads to the later appearance and progression of clinical symptoms. Early-changing Core 1 biomarkers (amyloid positron emission tomography [PET], approved cerebrospinal fluid biomarkers, and accurate plasma biomarkers [especially phosphorylated tau 217]) map onto either the amyloid beta or AD tauopathy pathway; however, these reflect the presence of ADNPC more generally (i.e., both neuritic plaques and tangles). An abnormal Core 1 biomarker result is sufficient to establish a diagnosis of AD and to inform clinical decision making throughout the disease continuum. Later-changing Core 2 biomarkers (biofluid and tau PET) can provide prognostic information, and when abnormal, will increase confidence that AD is contributing to symptoms. An integrated biological and clinical staging scheme is described that accommodates the fact that common copathologies, cognitive reserve, and resistance may modify relationships between clinical and biological AD stages.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
贤惠的忆南完成签到 ,获得积分10
6秒前
lq完成签到 ,获得积分10
9秒前
ChengYonghui完成签到,获得积分10
9秒前
开朗醉波完成签到,获得积分10
12秒前
wing完成签到 ,获得积分10
12秒前
racill完成签到 ,获得积分10
12秒前
小荣同学完成签到 ,获得积分10
13秒前
辛勤的松完成签到,获得积分10
18秒前
热心的小馒头完成签到 ,获得积分10
18秒前
潇洒的无声完成签到 ,获得积分10
18秒前
Rose完成签到,获得积分10
28秒前
恒恒666完成签到 ,获得积分10
29秒前
29秒前
31秒前
工艺纯化小天才完成签到 ,获得积分10
31秒前
隐形曼青的应助被Rose采纳,获得10
31秒前
霖29发布了新的文献求助10
34秒前
小小完成签到 ,获得积分10
40秒前
火星上的寒安完成签到 ,获得积分10
41秒前
白开水完成签到,获得积分10
41秒前
机智的孤兰完成签到 ,获得积分10
41秒前
彳亍完成签到,获得积分10
43秒前
Maestro_S的应助被科研通管家采纳,获得10
47秒前
281911480完成签到,获得积分10
49秒前
尊敬诗桃完成签到 ,获得积分10
51秒前
呆萌的宫苴完成签到 ,获得积分10
51秒前
25778完成签到 ,获得积分10
56秒前
cole完成签到,获得积分10
58秒前
爱听歌的沛儿完成签到 ,获得积分20
59秒前
眼睛大的寒蕾完成签到 ,获得积分10
1分钟前
dmm发布了新的文献求助20
1分钟前
孤独的问柳完成签到,获得积分10
1分钟前
DKX完成签到 ,获得积分10
1分钟前
幸福御姐完成签到,获得积分10
1分钟前
张啦啦完成签到 ,获得积分10
1分钟前
dididi完成签到 ,获得积分10
1分钟前
温淼完成签到,获得积分20
1分钟前
dmm完成签到,获得积分10
1分钟前
Owen的应助被温淼采纳,获得10
1分钟前
手握灵珠常奋笔完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185520
求助须知:如何正确求助?哪些是违规求助? 9574262
关于积分的说明 21834654
捐赠科研通 7783176
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558951
邀请新用户注册赠送积分活动 2481357